$56.28 +0.06 (%) Bristol-Myers Squibb Co - New York Stock Exchange, Inc.

Jan. 17, 2017 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. FDA Track Record Bodes Well For Merck Keytruda Plus Chemo: Leerink

    Investors Business Daily | Jan. 17, 2017 | 14:21PM EST
  2. Analysts See Merck Rally Continuing After Lung Cancer Drug News

    TalkMarkets | Jan. 12, 2017 | 14:31PM EST
  3. Eli Lilly Rebounds On Chemo-Drug Patent Win Vs. Generic Teva

    Investors Business Daily | Jan. 12, 2017 | 14:00PM EST
  4. Bristol-Myers Threatens Merck's 'Head Start' In Lung Cancer: Analyst

    Investors Business Daily | Jan. 12, 2017 | 11:14AM EST
  5. Stocks Wipe Away Losses, Close Higher; Drug Stocks Feel Trump Thump

    Investors Business Daily | Jan. 11, 2017 | 16:21PM EST
  6. Merck Lung-Cancer Drug May Get OK For Large Patient Population

    Investors Business Daily | Jan. 11, 2017 | 12:28PM EST
  7. Bristol-Myers slips after FDA gives Merck lung cancer therapy priority review

    TalkMarkets | Jan. 11, 2017 | 11:50AM EST
  8. Calithera Pharma In Focus, Part 3 - Arginase Inhibitor And Acquisition Target

    TalkMarkets | Jan. 9, 2017 | 07:51AM EST
  9. Biotech Blahs: Out Of Favor But Great For Stock Pickers

    TalkMarkets | Jan. 3, 2017 | 02:49AM EST
  10. Cempra Plunges To 52-Week Low, Shire Drug Label Expanded

    TalkMarkets | Dec. 30, 2016 | 10:33AM EST
  11. Stocks Going Ex Dividend the First Week of January

    TalkMarkets | Dec. 28, 2016 | 04:00AM EST
  12. J&J Back In Talks With Actelion, Teva Settles Corruption Probe

    TalkMarkets | Dec. 23, 2016 | 13:37PM EST
  13. Gilead Is A Hail Mary: 3 Better Stocks To Consider

    TalkMarkets | Dec. 23, 2016 | 12:21PM EST
  14. Biotechs Fade Again In Late Day Sell-Off

    TalkMarkets | Dec. 19, 2016 | 20:51PM EST
  15. Bristol-Myers Will Gain In Lung Cancer Square-Off Vs. Merck: Jefferies

    Investors Business Daily | Dec. 19, 2016 | 14:25PM EST
  16. Jefferies Says Sell Merck, Buy Bristol-Myers Heading Into New Year

    TalkMarkets | Dec. 19, 2016 | 12:48PM EST
  17. Incyte Could Step Onto Auction Block With Strong Jakafi Sales: RBC

    Investors Business Daily | Dec. 19, 2016 | 11:58AM EST
  18. Morning Call For Monday, Dec. 19

    TalkMarkets | Dec. 19, 2016 | 09:10AM EST
  19. The FDA: Small-Cap Catalyst Or Small-Cap Killer?

    TalkMarkets | Dec. 16, 2016 | 09:37AM EST
  20. Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks With ALIOF

    TalkMarkets | Nov. 28, 2016 | 11:59AM EST
  21. Calithera In Focus, Part 2 - Upcoming Catalysts In TNBC And RCC

    TalkMarkets | Nov. 23, 2016 | 11:45AM EST
  22. Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal

    TalkMarkets | Nov. 18, 2016 | 08:30AM EST
  23. Calithera Pharma In Focus Part 1 - Checkpoint Inhibition

    TalkMarkets | Nov. 16, 2016 | 07:21AM EST
  24. AskSlim Market Week - 11/11/16

    TalkMarkets | Nov. 11, 2016 | 22:29PM EST
  25. Rayno Biobeat #3…Trump Biotech Rally Leads Market Up

    TalkMarkets | Nov. 9, 2016 | 23:23PM EST
  26. Trump Triumphs

    TalkMarkets | Nov. 9, 2016 | 21:28PM EST
  27. Pharmaceutical Stocks Surge After Republican Victory

    TalkMarkets | Nov. 9, 2016 | 12:48PM EST
  28. Rayno Biobeat #2…Good Value in Large Cap Biopharmaceuticals

    TalkMarkets | Nov. 7, 2016 | 10:20AM EST
  29. Fundamentals Remain Strong In The Pharma Sector

    TalkMarkets | Nov. 5, 2016 | 18:49PM EST
  30. Biotech Meltdown: Financial Metrics Offer Few Clues For What is Next

    TalkMarkets | Nov. 1, 2016 | 06:52AM EST
  31. Surviving Hillary - Surviving Donald: The Election Portfolio

    TalkMarkets | Oct. 31, 2016 | 15:10PM EST
  32. Daily Update: Core Durable Goods Down 21 Straight Months

    TalkMarkets | Oct. 27, 2016 | 11:55AM EST
  33. Biotech Bear Market Looking For Relief From Q3 Large Cap Growth

    TalkMarkets | Oct. 26, 2016 | 20:45PM EST
  34. 5 Stocks To Watch Before The Market Opens Tomorrow (October 27, 2016)

    TalkMarkets | Oct. 26, 2016 | 16:50PM EST
  35. Big Pharma’s Big Biotech Problem

    Dividend.com | Oct. 12, 2016 | 08:00AM EST
  36. Bristol-Myers Falls As Merck Upstages With New Lung Cancer Data

    TalkMarkets | Oct. 10, 2016 | 18:35PM EST
  37. Earnings ESP

    TalkMarkets | Oct. 8, 2016 | 18:11PM EST
  38. Rayno 2016 Life Science Portfolio Update

    TalkMarkets | Sep. 29, 2016 | 20:14PM EST
  39. The Gap Inc. Leads 85 Stocks Going Ex-Dividend Next Week

    Dividend.com | Sep. 29, 2016 | 09:00AM EST
  40. Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO

    TalkMarkets | Sep. 23, 2016 | 12:15PM EST
  41. Trending on Dividend.com: Bristol-Myers Disappoints and DHT Surprises, While Wal-Mart Starts Race After Amazon

    Dividend.com | Aug. 12, 2016 | 15:00PM EST
  42. 3 Big Drugmakers That Beat Wall Street Q2 Estimates Thursday

    Investors Business Daily | Jul. 28, 2016 | 09:30AM EST
  43. Amazon, Alphabet, Baidu, Ford, Celgene On Tap Thursday

    Investors Business Daily | Jul. 27, 2016 | 16:45PM EST
  44. Investing Action Plan: Amazon, Alphabet, Baidu, Ford, Celgene

    Investors Business Daily | Jul. 27, 2016 | 12:51PM EST
  45. Investing Action Plan: Apple, Facebook, Amazon, Big Oil, Boeing, Fed

    Investors Business Daily | Jul. 23, 2016 | 07:00AM EST
  46. 5 Big Drugmakers Reporting Earnings Next Week

    Investors Business Daily | Jul. 22, 2016 | 12:57PM EST
  47. Ken Fisher's Best Investments: Credicorp, Ambev, Tata Motors

    GuruFocus | Jul. 11, 2016 | 04:31AM EST
  48. Bristol-Myers Looks To A Promising Future

    Benzinga | Feb. 17, 2016 | 08:17AM EST
  49. Barron's Picks And Pans: Bristol-Myers Squibb, KeyCorp, Core-Mark And More

    Benzinga | Feb. 14, 2016 | 14:09PM EST
  50. Intercept Pharma Spikes On Report That It’s Exploring A Sale

    IBD | Feb. 12, 2016 | 15:30PM EST
Trading Center